Ryan Ho-Yan Wong - 01 Dec 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Financial Officer
Signature
/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ryan Ho-Yan Wong
Issuer symbol
SRPT
Transactions as of
01 Dec 2025
Transactions value $
-$3,312
Form type
4
Filing time
10 Dec 2025, 20:05:03 UTC
Previous filing
05 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wong Ryan Ho-Yan Chief Financial Officer 215 FIRST STREET, CAMBRIDGE /s/ Cristin L. Rothfuss, as Attorney-in-Fact for Ryan Ho-Yan Wong 10 Dec 2025 0002079673

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability -$1.68K -80 -0.06% $20.96 136K 01 Dec 2025 Direct F1
transaction SRPT Common Stock Tax liability -$1.63K -78 -0.06% $20.96 136K 01 Dec 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2021.
F2 Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on November 30, 2022.